# Primerica share price today (Primerica, Inc., PRI)

> Primerica, Inc.'s earnings have grown faster than its share price. Earnings per share grew +67.2% in a year while the price moved +7.8%. PRI · Financials · Insurance - Life · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/pri

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: $280.23 (+7.8% in a year)
- P/BV: 3.4× (lower than 52% of the last 5.3 years)
- Revenue (Jun 2026): $878 M (+8.7% on a year ago)
- Profit (Jun 2026): $202 M (+13.4% on a year ago)
- Net margin: 23.0% (+0.9 points on a year ago)
- ROE: 33%, FY25
- ROA: 4.66%, latest

The main question: yearly earnings per share moved +67.2% while the share price moved +7.8%. ## What is the Primerica share price today? Primerica, Inc.'s share price was $280.23 at the close on 3 November 2026. It has been rising for 2 weeks. That is 0.5% above its average price over the last 200 trading days. In the last 52 weeks it traded between $246 and $321, and at that close it sat 46% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 7 weeks running. Over the last 10 years the share price moved +384% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Primerica pay? Primerica, Inc. paid $4.64 per share over the last four reported quarters. The most recent declaration was $1.20 for Jun 2026. At today's price of $280.23 that is a yield of 1.66%, based on dividends already paid, not a forecast. ## Which stock lists is Primerica on? Primerica is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Primerica profitable? Primerica, Inc. earned $202 M of net profit in the Jun 2026 quarter, +13.4% on the same quarter a year earlier. That is the 8th quarter in a row of profit growth. Full-year FY25 profit was $751 M. Over 4 years profit has grown 12.1% a year on average. That is 23.0% of the quarter's revenue. The same quarter a year earlier earned $178 M. For the full year, FY25 profit was $751 M (+59.7% on the year before). Why profit moved: revenue changed +8.7% on a year earlier and the margin moved +0.9 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +17.4% and revenue +8.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Primerica make, and is it growing? Primerica, Inc. reported $878 M of income in the Jun 2026 quarter, +8.7% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 4 years it has grown 4.8% a year on average. The last full year, FY25, came in at $3.3 B. The last four reported quarters add to $3.5 B. FY25 revenue was $3.3 B, +8.0% on the year before. Recent pace: the last four quarters grew +8.2% on average, against 4.8% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +8.2%, against +8.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +17.3%, against +34.1% a year (rolling over). ## How much does Primerica keep from what it earns? Primerica, Inc.'s net margin was 23.0% in the Jun 2026 quarter, 0.9 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 15.2% and 22.4%. The latest quarter is above every full year in that period. Across 5 years it has been between 15.2% and 22.4%, and FY25's 22.4% is the highest of them. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## How many of Primerica's loans have gone bad? Primerica, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Primerica's loan book growing? Primerica, Inc.'s revenue was $3.3 B in FY25, +8.0% on the year before, so the loan book is growing. The latest quarter was +8.7% on a year earlier. The net margin on that income is 23.0%, +0.9 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Primerica's P/BV ratio, and how does it compare with its own history? Primerica, Inc.'s P/BV is 3.4×, in the middle of its own history: higher than 48% of past readings. Its usual P/BV (the middle reading) is 3.5×, over 5.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Keep one thing in mind: the net margin is the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year book value grew while the price moved +7.8%. Price and book value moved together, so the multiple stayed in its range. Where the price move came from: over 5 years the price moved +9.6% a year; about +9.0% a year came from book-value growth and about +0.6 percentage points from the multiple (roughly no change). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the book value trend underneath matters more than the multiple. ## Is the Primerica business getting better or worse? Primerica, Inc.'s business is turning around. Profit growth has swung from −12.0% at its low to +17.3%, rising from a low 5 quarters ago, with ROE steady at 31.6%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## How much does Primerica earn on its equity and assets? Primerica, Inc. earned a return on equity of 31% in FY25. Its lowest yearly reading on file was 21% in FY24. On its assets, every $100 earned about $4.66, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That is above the level a bank needs to grow its net worth steadily. Why ROE moved: profit grew 12.1% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Primerica have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Primerica shareholding pattern? 4.4% of Primerica, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 6.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Primerica from balance-sheet trouble? For Primerica, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Primerica rank in its industry? 58.9 out of 100, rank 3 of 17 in Insurance - Life, with 76% of the evidence available. Primerica, Inc. scores 58.9 out of 100 against the 17 companies it is compared with in Insurance - Life, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.4 + 20.6 + 11.9 + 6 = 58.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Primerica compared with? Primerica ranks 3 of 17 Insurance - Life companies on the 4-Factor Sector Score, with 58.9 out of 100. 1. [Aflac Incorporated](https://www.sectoralpha.in/us/stocks/afl) AFL · turning · Most evidence points up · 76% evidence 70.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.3/35 · Income 13.6% · Profit 99.5% · 71% evidence Capital efficiency 17.0/25 · ROA 2.8% · ROE 13.7% · GNPA n/a · 68% evidence Valuation 10.5/20 · P/BV 1.97× · P/BV÷ROE 0.14 · 70% evidence Relative strength 15.5/20 · Lead over its industry 5.1% · Lead over S&P 500 2.7% · 1 year 8.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.3 + 17 + 10.5 + 15.5 = 70.3 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [F&G Annuities & Life, Inc.](https://www.sectoralpha.in/us/stocks/fg) FG · basing · Evidence leans up · 76% evidence 59.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.2/35 · Income 15% · Profit 23.6% · 71% evidence Capital efficiency 14.5/25 · ROA 0.9% · ROE 20.6% · GNPA n/a · 68% evidence Valuation 16.4/20 · P/BV 0.75× · P/BV÷ROE 0.04 · 70% evidence Relative strength 2.1/20 · Lead over its industry -21.8% · Lead over S&P 500 -23.7% · 1 year -30.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 26.2 + 14.5 + 16.4 + 2.1 = 59.2 · What this means: Earnings are strong; relative strength in its sector is -21.8% and the one-year return is -30.2%. 3. Primerica, Inc. this page PRI · quiet · Evidence leans up · 76% evidence 58.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Income 8.2% · Profit 17.4% · 71% evidence Capital efficiency 20.6/25 · ROA 4.5% · ROE 30.6% · GNPA n/a · 68% evidence Valuation 11.9/20 · P/BV 3.51× · P/BV÷ROE 0.12 · 70% evidence Relative strength 6.0/20 · Lead over its industry -0.5% · Lead over S&P 500 -2.7% · 1 year 10.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 20.4 + 20.6 + 11.9 + 6 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [MetLife, Inc.](https://www.sectoralpha.in/us/stocks/met) MET · leader · Evidence leans up · 76% evidence 57.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.1/35 · Income 8.8% · Profit -14.9% · 71% evidence Capital efficiency 13.8/25 · ROA 0.6% · ROE 16.4% · GNPA n/a · 68% evidence Valuation 11.9/20 · P/BV 1.95× · P/BV÷ROE 0.12 · 70% evidence Relative strength 18.4/20 · Lead over its industry 16.1% · Lead over S&P 500 13.6% · 1 year 32.2% · 100% evidence · 7 of 12 weeks ahead Exact sum: 13.1 + 13.8 + 11.9 + 18.4 = 57.2 · What this means: Relative strength against the index is 13.6%, and revenue and profit growth are weak. 5. [Prudential plc](https://www.sectoralpha.in/us/stocks/puk) PUK · basing · Too little evidence to rank firmly · 56% evidence 55.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Income n/a · Profit n/a · 15% evidence Capital efficiency 17.6/25 · ROA 2.9% · ROE 15.4% · GNPA n/a · 68% evidence Valuation 14.3/20 · P/BV 1.61× · P/BV÷ROE 0.1 · 70% evidence Relative strength 3.9/20 · Lead over its industry -14.1% · Lead over S&P 500 -16.2% · 1 year -11.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.2 + 17.6 + 14.3 + 3.9 = 55 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [Jackson Financial Inc.](https://www.sectoralpha.in/us/stocks/jxn) JXN · leader · Too little evidence to rank firmly · 55% evidence 53.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.4/35 · Income 14.6% · Profit n/a · 45% evidence Capital efficiency 8.2/25 · ROA 0.9% · ROE -16.6% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 0.68× · P/BV÷ROE n/a · 10% evidence Relative strength 19.8/20 · Lead over its industry 18.7% · Lead over S&P 500 16.2% · 1 year 51.4% · 100% evidence · 11 of 12 weeks ahead Exact sum: 15.4 + 8.2 + 9.8 + 19.8 = 53.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Lincoln National Corporation](https://www.sectoralpha.in/us/stocks/lnc) LNC · quiet · Evidence leans up · 64% evidence 52.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Income 7.5% · Profit 100% · 71% evidence Capital efficiency 6.4/25 · ROA 0.5% · ROE -6.5% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 0.6× · P/BV÷ROE n/a · 10% evidence Relative strength 11.7/20 · Lead over its industry 3.5% · Lead over S&P 500 1.1% · 1 year 2.6% · 100% evidence · 7 of 12 weeks ahead Exact sum: 24.8 + 6.4 + 9.8 + 11.7 = 52.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Manulife Financial Corporation](https://www.sectoralpha.in/us/stocks/mfc) MFC · turning · Evidence leans up · 76% evidence 52.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.3/35 · Income 5.9% · Profit 14.7% · 71% evidence Capital efficiency 9.9/25 · ROA 0.5% · ROE 9.4% · GNPA n/a · 68% evidence Valuation 8.3/20 · P/BV 1.74× · P/BV÷ROE 0.19 · 70% evidence Relative strength 16.1/20 · Lead over its industry 11.3% · Lead over S&P 500 8.9% · 1 year 34% · 100% evidence · 4 of 12 weeks ahead Exact sum: 18.3 + 9.9 + 8.3 + 16.1 = 52.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Globe Life Inc.](https://www.sectoralpha.in/us/stocks/gl) GL · quiet · Evidence leans up · 80% evidence 52.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.5/35 · Income 5.7% · Profit 3% · 81% evidence Capital efficiency 19.7/25 · ROA 3.2% · ROE 18.8% · GNPA n/a · 68% evidence Valuation 13.1/20 · P/BV 2.07× · P/BV÷ROE 0.11 · 70% evidence Relative strength 6.1/20 · Lead over its industry -0.4% · Lead over S&P 500 -2.7% · 1 year 19.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 13.5 + 19.7 + 13.1 + 6.1 = 52.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [Unum Group](https://www.sectoralpha.in/us/stocks/unm) UNM · breaking out · Evidence leans up · 76% evidence 52.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.4/35 · Income 3.4% · Profit -53.8% · 71% evidence Capital efficiency 14.2/25 · ROA 1.4% · ROE 8.4% · GNPA n/a · 68% evidence Valuation 10.1/20 · P/BV 1.32× · P/BV÷ROE 0.16 · 70% evidence Relative strength 16.5/20 · Lead over its industry 7.2% · Lead over S&P 500 4.9% · 1 year 16.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 11.4 + 14.2 + 10.1 + 16.5 = 52.2 · What this means: Relative strength against the index is 4.9%, and revenue and profit growth are weak. 11. [Prudential Financial, Inc.](https://www.sectoralpha.in/us/stocks/pru) PRU · turning · Evidence leans up · 76% evidence 50.7 out of 100 Growth Capital Valuation Relative
12. [Security National Financial Corporation](https://www.sectoralpha.in/us/stocks/snfca) SNFCA · quiet · Evidence leans down · 76% evidence 48.3 out of 100 Growth Capital Valuation Relative
13. [CNO Financial Group, Inc.](https://www.sectoralpha.in/us/stocks/cno) CNO · turning · Evidence leans down · 76% evidence 45.7 out of 100 Growth Capital Valuation Relative
14. [Abacus Global Management, Inc.](https://www.sectoralpha.in/us/stocks/abx) ABX · quiet · Evidence leans down · 67% evidence 43.9 out of 100 Growth Capital Valuation Relative
15. Citizens, Inc. CIA · turning · Most evidence points down · 76% evidence 33.9 out of 100 Growth Capital Valuation Relative
16. [Genworth Financial, Inc.](https://www.sectoralpha.in/us/stocks/gnw) GNW · quiet · Most evidence points down · 76% evidence 33.8 out of 100 Growth Capital Valuation Relative
17. [Brighthouse Financial, Inc.](https://www.sectoralpha.in/us/stocks/bhf) BHF · basing · Most evidence points down · 64% evidence 27.1 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Insurance - Life](https://www.sectoralpha.in/us/sectors/insurance-life), all 17 compared on one page. ## Which companies are close to Primerica in size? Primerica is the 9th largest of 16 Insurance - Life companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Unum Group, Globe Life Inc. and Jackson Financial Inc. Just below it: Lincoln National Corporation, CNO Financial Group, Inc. and Genworth Financial, Inc. ### Insurance - Life companies close in size

1. [Unum Group](https://www.sectoralpha.in/us/stocks/unm) $14.4 billion
2. [Globe Life Inc.](https://www.sectoralpha.in/us/stocks/gl) $12.2 billion
3. [Jackson Financial Inc.](https://www.sectoralpha.in/us/stocks/jxn) $9.5 billion
4. Primerica, Inc. $8.6 billion
5. [Lincoln National Corporation](https://www.sectoralpha.in/us/stocks/lnc) $8.1 billion
6. [CNO Financial Group, Inc.](https://www.sectoralpha.in/us/stocks/cno) $5.3 billion
7. [Genworth Financial, Inc.](https://www.sectoralpha.in/us/stocks/gnw) $3.4 billion

[All 16 Insurance - Life companies, largest first](https://www.sectoralpha.in/us/sectors/insurance-life#all-companies)

### Companies close in size in other industries

1. [SentinelOne, Inc.](https://www.sectoralpha.in/us/stocks/s) $8.8 billion · Software - Infrastructure
2. [TTM Technologies, Inc.](https://www.sectoralpha.in/us/stocks/ttmi) $8.7 billion · Electronic Components
3. Primerica, Inc. $8.7 billion
4. [Advanced Energy Industries, Inc.](https://www.sectoralpha.in/us/stocks/aeis) $8.7 billion · Electrical Equipment & Parts
5. [Corcept Therapeutics Incorporated](https://www.sectoralpha.in/us/stocks/cort) $8.7 billion · Biotechnology

## What else do people ask about Primerica? ### What were Primerica's latest quarterly results? Primerica, Inc. reported total income of $878 M and net profit of $202 M for the Jun 2026 quarter. Income rose 8.7% and profit rose 13.4% compared with a year earlier. Earnings per share were $6.45. The net margin was 23.0%, 0.9 percentage points higher than a year earlier (as of 3 November 2026). ### What is Primerica's market cap? Primerica, Inc.'s market capitalisation is $8.6 B at a stock price of $280.23. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Primerica performing? Primerica, Inc.'s share price has been rising for 2 weeks. In its latest quarter, income rose 8.7% and profit rose 13.4% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 7 weeks running (as of 3 November 2026). ### Will Primerica's stock price go up? This page does not forecast Primerica, Inc.'s stock price. What it shows instead: the stock price is $280.23, and it has been rising for 2 weeks. Its P/BV of 3.4× is higher than 48% of its own last 5 years (as of 3 November 2026). ### Where is Primerica in its business cycle? Primerica, Inc.'s FY25 net margin was 22.4%, against a 5-year range of 15.2% to 22.4%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 23.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Primerica story? The main question: yearly earnings per share moved +67.2% while the share price moved +7.8%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Primerica a stock worth studying right now? What the numbers show: Primerica, Inc.'s earnings have grown faster than its share price. Earnings per share grew +67.2% in a year while the price moved +7.8%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.